An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer-Reference-Cited by-同舟云学术

An Intraprostatic Modified Release Formulation of Antiandrogen 2-Hydroxyflutamide for Localized Prostate Cancer

Published:2017-12 Issue:6 Volume:198 Page:1333-1339
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Tammela Teuvo L.¹²³⁴⁵,Häggman Michael¹²³⁴⁵,Ladjevardi Sam¹²³⁴⁵,Taari Kimmo¹²³⁴⁵,Isotalo Taina¹²³⁴⁵,Lennernäs Hans¹²³⁴⁵,Weis Jan¹²³⁴⁵,von Below Catrin¹²³⁴⁵,Wassberg Cecilia¹²³⁴⁵,Lennernäs Bo¹²³⁴⁵,Tolf Anna¹²³⁴⁵,Axén Niklas¹²³⁴⁵,Gölander Carl-Gustaf¹²³⁴⁵,Ahlström Håkan¹²³⁴⁵

Affiliation:

1. Department of Urology, Tampere University Hospital and University of Tampere (TLT), Tampere, Finland

2. Department of Urology, Helsinki University Hospital (KT), Helsinki, Finland

3. Department of Urology, Päijät-Häme Central Hospital (TI), Lahti, Finland

4. Department of Urology, Uppsala University Hospital (MH, SL), Uppsala, Sweden

5. Radiology, Department of Surgical Sciences (JW, CvB, CW), Uppsala University, Uppsala, Sweden

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference23 articles.

1. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study;Fitzmaurice;JAMA Oncol,2017